Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer

Berman, Abigail T.; DeCesaris, C.; Simone, Charles B.; Vachani, Carolyn; DiLullo, Gloria A; Hampshire, Margaret K.; Metz, James M.; Hill‐Kayser, Christine

doi:10.1200/jop.2015.008904

Cited by 16 publications

(19 citation statements)

References 17 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, this number is lower than previous studies utilizing responses from the OncoLink SCP tool for other cancer sites (16)(17)(18)(19). As many pancreatic cancer patients are anticipated to live with incurable disease from time of diagnosis or to relapse soon after treatment, providers may defer provision of an SCP.…”

Section: Discussionmentioning

confidence: 63%

Survivorship after treatment of pancreatic cancer: insights via an Internet-based survivorship care plan tool

Frick

Vachani

Hampshire

et al. 2017

J. Gastrointest. Oncol.

Self Cite

View full text Add to dashboard Cite

Pancreatic cancer survivors face a unique set of challenges in survivorship, yet structured survivorship care planning is lacking in practice. Survivorship care plans (SCPs) are an essential part of quality cancer care and can facilitate the transition following active treatment; the use of SCPs in pancreatic cancer survivors, however, has not been explored. With a convenience sample of 117 pancreatic cancer survivors and proxies who used an Internet-based SCP tool, we examined treatment details, patientreported outcomes, and survivorship practices. Thirty-one percent of survivors were 2 years or greater from diagnosis with a median current age of 62 years. Most patients had received multimodality therapy (67%): 68%, 86%, and 43% reported surgical intervention, intravenous chemotherapy, and radiation therapy for their pancreatic cancer, respectively. Survivors commonly reported fatigue, cognitive change, neuropathy, pancreatic insufficiency, and chronic radiation dermatitis related to treatment. Most survivors are managed (47%) or co-managed (35%) by an oncology specialist; however, this percentage decreases over time with consequent increase in management by primary care providers alone. Only 5% had previously been offered an SCP. Of the 24 users who responded to a follow-up satisfaction survey, 83% indicated they would share the SCP with their healthcare team although half of respondents felt it should include more information.In all, our results demonstrate that there is a population of pancreatic cancer survivors who exist and seek survivorship support although structured survivorship care planning is lacking in practice. SCPs have a potentially valuable role for these survivors via communication of treatment-related effects and coordination across multidisciplinary healthcare teams. Further development and evaluation of SCPs is needed for this underserved survivor population.

show abstract

Section: Discussionmentioning

confidence: 63%

Survivorship after treatment of pancreatic cancer: insights via an Internet-based survivorship care plan tool

Frick

Vachani

Hampshire

et al. 2017

J. Gastrointest. Oncol.

Self Cite

View full text Add to dashboard Cite

show abstract

“…For example, utilizing OncoLink PRO of lung cancer patients, it was determined that neurocognitive and musculoskeletal side effects caused a high incidence of morbidity, something that physicians did not focus on for this particular disease site. 31 In the study reported here, survivors reported some toxicities, such as dysphagia, that might have been anticipated by providers, but reported others, such as fatigue, that are often minimized by health care providers despite significant impact on quality of life.…”

Section: Discussionmentioning

confidence: 66%

Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity

Peach

Trifiletti

Vachani

et al. 2018

PROM

Self Cite

View full text Add to dashboard Cite

PurposeHead and neck cancer is occurring in an increasingly younger patient population, with treatment toxicity that can cause significant morbidity. Using a patient guided, Internet-based survivorship care plan program, we obtained and looked at patterns of patient-reported outcomes data from survivors seeking information after treatment for head and neck cancer.MethodsThe Internet-based OncoLife and LIVESTRONG Care Plan programs were employed, which design unique survivorship care plans based on patient-reported data. Care plans created for survivors of head and neck cancer were used in this evaluation. Demographics, treatment modality, and toxicity were included in this evaluation. Toxicity was further analyzed, grouped into system-based subsets.ResultsA total of 602 care plans were created from self-identified head and neck cancer survivors, from which patient-reported outcome data were attained. A majority of patients were Caucasian (96.2%) with median age at diagnosis of 55 years, living in suburban locations (39.9%), with ~50% receiving care within 20 miles of their residence. There was an equal distribution of education levels from high school only to graduate school. The majority of patients received care through cancer centers (96.7%), with a split between academic and non-academic centers. Ninety-three percent of patients had radiation therapy as part of their treatment modality, with 70.3% having chemotherapy and 60.1% having surgery. The most common system toxicities affected the oropharynx, followed by epithelium (skin/hair/nail), and then general global health. Specifically, the most common side effects were difficulty swallowing (61.5%) and changes in skin color/texture (49.7%). One third of patients experienced hearing/tinnitus/vertigo, xerostomia, loss of tissue flexibility, or fatigue.ConclusionThe current work demonstrates the ability to obtain patient-reported outcomes of head and neck cancer survivors through an Internet-based survivorship care plan program. For this group dysphagia and dermatitis were the most commonly reported toxicities, as was expected; however, global effects of therapy, such as fatigue, were also significant and should be addressed in future survivorship planning.

show abstract

“…That so few survivors report previous receipt of survivorship information suggests that these communication tools are still underutilized in this population. Furthermore, this number is lower than previous studies utilizing responses from the OncoLink SCP tool for other cancer sites (16)(17)(18)(19). As many pancreatic cancer patients are anticipated to live with incurable disease from time of diagnosis or to relapse soon after treatment, providers may defer provision of an SCP.…”

Section: Discussionmentioning

confidence: 90%

Survivorship after Treatment of Pancreatic Cancer: Insights Via an Internet-Based Survivorship Care Plan Tool

Frick

Vachani

Hampshire

et al. 2017

International Journal of Radiation Oncology*Biology*Physics

View full text Add to dashboard Cite

Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer

Cited by 16 publications

References 17 publications

Survivorship after treatment of pancreatic cancer: insights via an Internet-based survivorship care plan tool

Survivorship after treatment of pancreatic cancer: insights via an Internet-based survivorship care plan tool

Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity

Survivorship after Treatment of Pancreatic Cancer: Insights Via an Internet-Based Survivorship Care Plan Tool

Contact Info

Product

Resources

About